49 related articles for article (PubMed ID: 20969571)
1. Voltage-dependent and -independent block of α-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor channels.
Barygin OI; Luchkina NV; Tikhonov DB
J Neurochem; 2010 Dec; 115(6):1621-32. PubMed ID: 20969571
[TBL] [Abstract][Full Text] [Related]
2. Design of antagonists for NMDA and AMPA receptors.
Bolshakov KV; Kim KH; Potapjeva NN; Gmiro VE; Tikhonov DB; Usherwood PN; Mellor IR; Magazanik LG
Neuropharmacology; 2005 Aug; 49(2):144-55. PubMed ID: 15996563
[TBL] [Abstract][Full Text] [Related]
3. Organic blockers escape from trapping in the AMPA receptor channels by leaking into the cytoplasm.
Tikhonova TB; Barygin OI; Gmiro VE; Tikhonov DB; Magazanik LG
Neuropharmacology; 2008 Mar; 54(4):653-64. PubMed ID: 18178227
[TBL] [Abstract][Full Text] [Related]
4. AMPA receptors in epilepsy and as targets for antiepileptic drugs.
Rogawski MA; Donevan SD
Adv Neurol; 1999; 79():947-63. PubMed ID: 10514878
[TBL] [Abstract][Full Text] [Related]
5. Characterization of ionotropic glutamate receptors in insect neuro-muscular junction.
Fedorova IM; Magazanik LG; Tikhonov DB
Comp Biochem Physiol C Toxicol Pharmacol; 2009 Apr; 149(3):275-80. PubMed ID: 18723120
[TBL] [Abstract][Full Text] [Related]
6. Non-classical mechanism of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor channel block by fluoxetine.
Barygin OI; Komarova MS; Tikhonova TB; Tikhonov DB
Eur J Neurosci; 2015 Apr; 41(7):869-77. PubMed ID: 25557871
[TBL] [Abstract][Full Text] [Related]
7. Voltage-dependent block of native AMPA receptor channels by dicationic compounds.
Tikhonov DB; Samoilova MV; Buldakova SL; Gmiro VE; Magazanik LG
Br J Pharmacol; 2000 Jan; 129(2):265-74. PubMed ID: 10694232
[TBL] [Abstract][Full Text] [Related]
8. Two mechanisms of action of the adamantane derivative IEM-1460 at human AMPA-type glutamate receptors.
Schlesinger F; Tammena D; Krampfl K; Bufler J
Br J Pharmacol; 2005 Jul; 145(5):656-63. PubMed ID: 15834439
[TBL] [Abstract][Full Text] [Related]
9. Uncompetitive antagonism of AMPA receptors: Mechanistic insights from studies of polyamine toxin derivatives.
Andersen TF; Tikhonov DB; Bølcho U; Bolshakov K; Nelson JK; Pluteanu F; Mellor IR; Egebjerg J; Strømgaard K
J Med Chem; 2006 Sep; 49(18):5414-23. PubMed ID: 16942015
[TBL] [Abstract][Full Text] [Related]
10. YM90K: pharmacological characterization as a selective and potent alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist.
Shimizu-Sasamata M; Kawasaki-Yatsugi S; Okada M; Sakamoto S; Yatsugi S; Togami J; Hatanaka K; Ohmori J; Koshiya K; Usuda S; Murase K
J Pharmacol Exp Ther; 1996 Jan; 276(1):84-92. PubMed ID: 8558460
[TBL] [Abstract][Full Text] [Related]
11. Novel AMPA receptor antagonists: synthesis and structure-activity relationships of 1-hydroxy-7-(1H-imidazol-1-yl)-6-nitro-2,3(1H,4H)- quinoxalinedione and related compounds.
Ohmori J; Shimizu-Sasamata M; Okada M; Sakamoto S
J Med Chem; 1996 Sep; 39(20):3971-9. PubMed ID: 8831762
[TBL] [Abstract][Full Text] [Related]
12. Argiotoxin in the closed AMPA receptor channel: experimental and modeling study.
Barygin OI; Grishin EV; Tikhonov DB
Biochemistry; 2011 Sep; 50(38):8213-20. PubMed ID: 21842876
[TBL] [Abstract][Full Text] [Related]
13. Block of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors by polyamines and polyamine toxins.
Washburn MS; Dingledine R
J Pharmacol Exp Ther; 1996 Aug; 278(2):669-78. PubMed ID: 8768718
[TBL] [Abstract][Full Text] [Related]
14. Blockade of NMDA receptor channels by 9-aminoacridine and its derivatives.
Barygin OI; Gmiro VE; Kim KKh; Magazanik LG; Tikhonov DB
Neurosci Lett; 2009 Feb; 451(1):29-33. PubMed ID: 19111901
[TBL] [Abstract][Full Text] [Related]
15. The new 2,3-benzodiazepine derivative EGIS-8332 inhibits AMPA/kainate ion channels and cell death.
Vegh MG; Kovács AD; Kovács G; Szabó G; Tihanyi K; Hársing LG; Lévay G
Neurochem Int; 2007 Feb; 50(3):555-63. PubMed ID: 17147974
[TBL] [Abstract][Full Text] [Related]
16. Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes.
Stein E; Cox JA; Seeburg PH; Verdoorn TA
Mol Pharmacol; 1992 Nov; 42(5):864-71. PubMed ID: 1279377
[TBL] [Abstract][Full Text] [Related]
17. Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices.
Frade JG; Barbosa RM; Laranjinha J
Hippocampus; 2009 Jul; 19(7):603-11. PubMed ID: 19115375
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of inhibition of the GluR2 AMPA receptor channel opening by 2,3-benzodiazepine derivatives.
Ritz M; Micale N; Grasso S; Niu L
Biochemistry; 2008 Jan; 47(3):1061-9. PubMed ID: 18161947
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of NMDA and AMPA/kainate receptor antagonists on nitric oxide production in rat brain following intrahippocampal injection.
Radenovic L; Selakovic V
Brain Res Bull; 2005 Sep; 67(1-2):133-41. PubMed ID: 16140172
[TBL] [Abstract][Full Text] [Related]
20. Positive modulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors in prefrontal cortical pyramidal neurons by a novel allosteric potentiator.
Baumbarger PJ; Muhlhauser M; Zhai J; Yang CR; Nisenbaum ES
J Pharmacol Exp Ther; 2001 Jul; 298(1):86-102. PubMed ID: 11408529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
